Cita APA (7a ed.)

MM, O., A, T., H, K., R, M., BI, A., MB, R., . . . NR, P. (2019). TKI-resistant ALK-rearranged lung adenocarcinoma with secondary CTNNB1 p.S45V and tertiary ALK p.I1171N mutations. Dove Medical Press.

Cita Chicago Style (17a ed.)

MM, Ouseph, Taber A, Khurshid H, Madison R, Aswad BI, Resnick MB, Yakirevich E, Ali SM, y Patel NR. TKI-resistant ALK-rearranged Lung Adenocarcinoma with Secondary CTNNB1 P.S45V and Tertiary ALK P.I1171N Mutations. Dove Medical Press, 2019.

Cita MLA (8a ed.)

MM, Ouseph, et al. TKI-resistant ALK-rearranged Lung Adenocarcinoma with Secondary CTNNB1 P.S45V and Tertiary ALK P.I1171N Mutations. Dove Medical Press, 2019.